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Microfluidics has geniuses of low consumption of reagents and sample, 
miniaturization of device, and fast turnaround time for analysis that enables to develop 
high-speed, high-resolution, portable bio-analysis devices to be immediately used at the 
point-of-care and homebased assays. Here, we established a versatile microfluidic 
system incorporating micro-arrays of individually addressable electrodes (patterned 
along the microchannel floor, 50 µm wide, 250 µm edge-to-edge spacing) that make it 
possible to transport charged macromolecules from the bulk solution to an electrode 
surface where they become compacted into an ultra-thin film. Using this principle, we 
focused on seeking new detection strategies (label-free detection), new applications 
(encapsulated microbubble synthesis, protein crystallization), and tried to get the 
diagnostics method out of the laboratory by using pervasive smartphone optics. 
 
First, we used DNA as a probe to build up a label-free detection system with 
microfabricated platinum electrode arrays in free solution and without the need of 
conventional labeling. Simply applying a DC potential (1-3 V) and illuminating the 
electrode surface, we could observe the surface reflectivity of microbubbles responsible 
from the electrolysis of water (with a threshold of ~1.3 V), which is stabilized by the 
highly compacted DNA film at the electrode surface. This effect is reversible and can be 
applied to proteins and other charged analytes to be detected. The interplay between 
microscale electrokinetics and electrochemistry can also be harnessed to simultaneously 
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confine macromolecular encapsulants near an electrode surface while inflating them 
with electrochemically generated gasses to synthesize tunable encapsulated 
microbubbles. 
 
Microfabricated chromium electrode arrays demonstrate another unlabeled 
detection approach by monitoring electrode degradation under ordinary white-light 
illumination. This reaction is highly compositional and size dependence that provides a 
possibility for real-time PCR detection application. Further, since dissolution is readily 
observable owing to the relatively large electrode sizes involved, we incorporated this 
microsystem with an Apple iPhone 4S to demonstrate the feasibility of smartphone-
based detection for near point-of-care application. 
 
Protein crystallization has also been demonstrated by transparent electrode arrays 
with hen egg white lysozyme via electrokinetic actuation to pre-concentrate protein 
molecules and to migrate the movement of certain ions simultaneously that enables to 
obtain single crystals in a short timescale (1-2 hours) and without previous purification. 
This technique provides capabilities for a straightforward interface of in-situ x-ray 
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CHAPTER I  
INTRODUCTION 
 
Incredible advances have been made toward the development of microfluidic 
systems capable of performing a wide range of chemical and biochemical analysis 
operations. This progress has been driven by the compelling benefits of miniaturization, 
including reduced reagent consumption and an increased capacity for automation so that 
the costs of performing reactions can be dramatically lowered. However, the necessity 
for high-performance and rapid capabilities micrototal-analysis-systems (µ-TAS) and 
lab-on-a-chip devices to operate in hospitals and emergency treatment in ambulances or 
disaster sites has never been more relevant. Thus, developing high-speed, high-
resolution, portable bio-analysis devices which can be immediately used at the point-of-
care (POC), homebased and field-based assays becomes a very important research topic. 
 
1.1 Microfluidics Meets Requirements of Point-of-Care Applications 
Considering the features of microfluidics, including low consumption of reagents 
and sample, miniaturization of device, and fast turnaround time for analysis, it is a nature 
fit for a POC diagnostics device, which performs at near-patient testing in a hospital, 
doctor’s office, clinic, or home without the use of laboratory staff and facilities to 
receive the result in seconds to hours[1]. Thus, there is no surprise that a growing 
research has focused on microfluidic-baesd application in POC sensors and diagnostics 
(Figure 1.1). The diagnostic samples for POC testing can be blood, saliva, urine, or other 
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bodily fluids or solids, and the targets include proteins, nucleic acids, metabolites, 
dissolved ions, microbes and so on[2].  Table 1.1 shows a variety of liquid samples from 
body fluids may be routinely analyzed in POC testing[3].  
 
 
Figure 1.1 Annual trends in the number of publication for microfluidic-based point-of-
care, point-of-care, and DNA biosensor. The terms “microfluidic point of care 
detection*”, “point of care diagnostic*”, “point of care detection*”, “gene array*”, “gene 
chip*”, “DNA biosensor*”, “DNA array*”, “DNA sensor*”, “genosensor*”, “DNA 
biochip*”, “DNA chip*”, “DNA microarry*” have been considered. The literature 





























Table 1.1 Variety of samples for diagnostics[3].  
sample Relevant composition Typical tests 
Blood 45% hematocrit: erythrocytes, reticulocytes, platelets, leukocytes 55% plasma 
Blood typing, genetic, cardiovascular, 
metabolism, infectious disease, cancer, drug 
and hormone monitoring 
Plasma Albumin, globulins, clotting factors, hormones, glucose and ions 
Genetic, cardiovascular, metabolism, 
infectious disease, cancer, drug and hormone 
monitoring 
Saliva Proteins, nucleic acids, proteolytic enzymes, enzymes from bacteria, bacteria 
Mostly qualitative: genetic, cardiovascular, 
metabolism, infectious disease, cancer, drug 
and hormone monitoring 
Urine Metabolites, ions Abnormal: protein, blood cells, pathogens 
Metabolism, liver, kidney, pregnancy, drug 
and hormone monitoring 
Stool Bacteria, fiber, cells Abnormal: blood, undigested nutrients 
Digestive tract diseases (liver, pancreas, 
colon), parasites, infectious disease 
Amniotic, cerebrospinal, 
lymphatic fluid 
Cells, proteins and nucleic acids Abnormal: 
pathogens 
Genetic mutations, infectious disease, 
metabolism 
Liquid from puncture of lung, 
pleura, ascites (abdomen) or joint Cells, proteins and nucleic acids 




1.1.1 Essentials of Idealized Microfluidic-Based POC Device 
The easier successful POC tests for diagnosis involve the lateral flow tests, which 
require only addition of sample, and are well known as pregnancy test and widely used 
to human immunodeficiency virus (HIV) diagnosis in developing countries. Although 
these tests are simple to perform by untrained people, the analysis does not mimic the 
multi-steps handling in laboratory-based procedures, which raises a consideration of 
producing highly reproducible, quantitative, and sensitive results[4]. Another well known 
successful POC test is the blood glucose test, which has improved diabetic patients’ lives 
and occupied most of the diagnostics market. However, the glucose test is based on a 
unique biochemical reaction and the concentration of the analytes is in the mM rang, 
which is far exceeds the concentration of most diagnostics markers[4]. Therefore, a 
microfluidic-based device, which can achieve real clinical requirements and detect low 
concentration of targets with an ability of quantify, will open a new page for the next 
generation of POC testing in healthcare. Figure 1.2 displays an idealized concept of a 
microfluidic-based POC device, which is challenged by small sample volumes (hundreds 
of nanoliters to ~1 mL) and conducts complex biological media with femtomolar to 
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integrate the varied microfluidic technologies into a single disposable platform, which 
means the peripheral equipment (microscopes, pumps, readers, etc.) has to be merged for 
processing and analyzing a sample, and reporting the results on a chip. In addition, the 
size and the weight of the devices, as well as the energy consumption, need to be 
minimized for the portability.  Typically, microfluidic devices require manufacturing 
processes that are expensive and non-scaleable.  Therefore, using inexpensive materials 
(e.g., paper[7]), low-cost manufacturing and packing methods, and pervasive detection 
device (e.g., cameras from consumer electronics[8, 9]) to get the diagnostics out of the 
laboratories are the new trends in the future.  
 
Summarily, the future trends and technologies for the microfluidic-based POC 
devices include three main ways: 
• New materials, to reduce cost and complement the current focus on planar 
microfluidics. (e.g., paper as substrate, materials that enable autonomous ) 
• New detection strategies (e.g., label-free detection) 
• New applications (e.g., investment in $1000 whole-genome sequencing may 
accelerate the development of POC molecular testing)[10] 
 
1.2  Strategies for Detection of Biomolecules in Microfluidic Systems 
There are over 6000 experimental procedures available with subspecifications for 
medicinal laboratory diagnostics[11]. The testing materials are very diverse and 
depending upon its origin and nature, which have been showed in Table 1.1. The most 
 7 
 
important methods have been selected and listed in Table 1.2. Opportunely, a number of 
approaches have been investigated to perform biomolecules detection in microfluidic 
systems[12, 13], which can be classified into several major types: optical methods[14-22], 
electrochemical methods[23-27], mass spectrometry (MS) methods[28, 29], nuclear magnetic 
resonance (NMR) spectroscopy[30], magnetoresistive[31], and acoustical[32]. In regard to 
the selectivity and sensitivity, optical and electrochemical methods are the most 
frequently utilized. 
 
1.2.1 Optically-Based Technologies 
Among these methods, optically-based technologies are the most mature and 
popular methods, which can be broadly categorized into two groups, namely labeled 
methods and label-free methods. In labeled methods, biomolecules (e.g., DNA or 
proteins) are detected by fluorescent labeling, which has been largely used in optically-
based study of molecular interactions. But these approaches are also subject to important 
drawbacks including the additional time and expense required to perform chemical 
labeling, and the possibility that fluorescent tags may render the biomolecules 
incompatible with subsequent reactions[33]. Another important drawback is that sensitive 
macro-scale optical detection instrumentation is typically needed because the levels of 
emitted fluorescence are inherently low. The size, complexity, and cost of these 





Table 1.2 The important analytical procedure for the routine determination of analytes.[11] 
Spectrometry Electrophoresis 
• absorption spectroscopy/photometry 
• UV/Vis/NIR/IR spectroscopy 
• atomic absorptions spectroscopy 
(AAS) 
• atomic fluorescence spectroscopy 
(AFS) 
•  NMR spectroscopy 




fluorescence polarization and 
phosphorescence spectroscopy 
•  nephelometry/ 
immunonephelometry 
•  turbidimetry/ 
immunoturbidimetry 
• atomic emission 
spectroscopy (AES) 
• flame emission spektroscopy 
• ICP mass spectrometry 
(ICP-MS), MALDI-TOF-MS 
 




• isoelectric focusing 
• pulse-field gel electrophoresis 
• counterimmune electrophoresis 
(countercurrent electrophoresis) 
• isotachophoresis 
• capillary electrophoresis 
• rocket electrophoresis 
Ligand Assays Electrochemical Studies 
• enzyme immunoassay 
• fluorescence immunoassay 
• immunoblot (Western blot) 
• luminescence and 
electrochemiluminescence 
immunoassay (CLIA/ECLIA) 
• fluorescence polarization enzyme 
immunoassay 
• radioimmunoassay 
• receptor assay 
• amperometry: O2 partial pressure 
(Clark electrode) 
• potentiometry: pH value, CO2 




Chromatography Molecular Biological Methods 
• thin-layer chromatography (TLC) 
• liquid chromatography (LC) 
• gas chromatography (GC) and 
GC-MS 
• high-performance liquid 
chromatography (HPLC) and 
HPLC-MS 
• (real-time) polymerase chain 
reaction 
• Southern blot 
• fluorescence in situ hybridization 
(FISH) 
• evidence for single-nucleotide 
polymorphisms (SNPs) with, e.g. 
restriction fragment length 
polymorphisms (RFLPs), FRET 
probes (FRET: fluorescence 
resonance energy transfer), density 
gradient gel electrophoresis 





As a result of the above drawbacks of labeled technologies, researches have been 
exploring the area of label-free detection to overcome these problems, including 
autofluorescence[16], confocal Raman spectroscopy[19], intracavity spectroscopy[20], 
optical scattering[15] and surface plasmon resonance (SPR)[34, 35]. However, most of these 
techniques have been developed for biophysical studies, which are hindered by the bulky 
and expensive equipment needed, and limited cell and biomolecule manipulation. 
Electrochemical detection is also explored as label-free alternative because of the 
capability of providing direct electrical output signals based on amperometry[23, 24], 
conductimetry[25, 26], and potentiometry[27]. Also, electrochemical detection is highly 
amenable to miniaturization, which has been demonstrated for detection of analytes 
during capillary electrophoresis[36] as well as for sensing of hybridization at 
functionalized electrode surfaces[37]. Although electrochemical detection can be applied 
to detect charged molecules, detection of DNA in free solution still requires addition of 
electrochemically active intercalation agents and is not particularly sensitive to low 
DNA concentrations[13, 38]. 
 
The typical optical detection methods involve the detection by directly 
monitoring the light properties, including fluorescence[18, 39, 40], absorbance[21], and 
luminescence[22], and the light property modulation such as surface plasmon resonance 
(SPR)[34, 35], which have been demonstrated in Figure 1.3. Although SPR techniques 
have been widely used for detection of binding events at surfaces, they are generally 











































tion of the e

































































ins to be ov
d integrate



















n for MS 
cation from 

































































































em, (b) the 


































1.3 Current Technologies and Challenges of Nucleic Acid Testing for Microfluidic-
Based Point-of-Care Applications 
Researches for microfluidic-based POC devices are still emerging; particularly, 
there is an increasing clinical demand in high-throughput deoxyribonucleic acid (DNA) 
detection to assist monitor and diagnostics at the POC testing. Thus, we can see a 
tremendously growing research on the DNA biosensors over the past ten years as 
demonstrated by the large number of scientific publications (Figure 1.1). However, most 
of the available POC devices on the market are based on immunoassays. The Cepheid 
GeneXpert, a polymerase chain reaction (PCR)-based system, is currently the only 
moderate complexity nucleic acid testing (NAT) platform approved in the USA, but the 
system is still relatively expensive and complex that is still inappropriate for POC setting 
and can only be used in hospital[43]. Compared to equivalent laboratory tests, the POC 
testing is usually more expensive per test, although a true cost comparison needs to 
consider central laboratory overhead costs, better management, and disease 
containment[44].   Undeniably, nevertheless, POC NAT still provides much needed in the 
developing countries, which have limited financial resources, for example, the efforts are 
underway on HIV, tuberculosis (TB)[45-47], and enteric diseases[48]. For the developed 
countries, POC NAT provides a more personalized healthcare for immediate clinical 
management decisions that can ensure optimal use of medical resource. Additionally, 
Gascoyne et al.[49] compared different methods for Malaria detection and pointed out the 
genetic detection methods would offer significant advantages if they would be 
implemented in a µ-TAS format.   
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1.3.1 Demands of Microfluidic-Based POC NAT Applications 
We expect POC NAT can provide much-needed diagnostic methods in low-
resource, high disease-burden areas, but it has not been found widespread use in the 
world and a complete µ-TAS platform has not been successfully commercialized yet. 
The main reason is the requirement of a comprehensive tool-chain (e.g., PCR, 
electrophoresis, and fluorescence reader) and some case need high cost of integrated 
tools hybridization assays[5]. Thus, the greatest challenge for microfluidic-based POC 
NAT applications is combination of the principal NAT steps, sample preparation, 
amplification, and detection which usually use high-end instrumentation and skilled 
personnel, into one integrated and automated system. Table 1.3 listed examples of fully 
or partially integrated platforms that are commercially available or close to market[43, 50], 
but the time to result still needs ~1-2 hours and the formats are still laboratory-based 
NAT, close to the benchtop system (Figure 1.6).  
 
1.3.2 Sample Preparation Is the Key 
In general, sample preparation is a bottleneck in NAT, especially for 
microfluidic-based POC application[50], because it involves lengthy and varied processes 
that are often manually performed. For example, lysis needs to be performed by 
chemical or enzymatic means, and some microorganisms are very difficult to lyse. 
Meanwhile, nucleic acid purification is a necessary step because the subsequent target 
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Table 1.3 Examples POC NAT platforms that that are commercially available or close to market[43, 50]. 
Platform Manufacturer Integrated 
Sample 
Preparation 




GeneXpert Cepheid Yes Real-time PCR RTF <120 http://www.cepheid.com/ 
Liat 
Analyzer IQuum Yes Real-time PCR RTF <60 http://www.iquum.com/ 
FL/ML Enigma Yes Real-time PCR RTF <45 http://www.enigmadiagnostics.com/ 




RTT <60 http://www.eiken.co.jp/ 





RTF <20 http://www.twistdx.co.uk/ 




RTB <60 http://www.lumora.co.uk/ 




RTF <20 http://www.optigene.co.uk/ 
a RTB: real-time bioluminescence; RTF: real-time fluorescence; RTT: real-time turbidimetry 




1.3.3 Concentration Desires to Be Improved 
Although microfluidic technologies have enabled increasingly sophisticated 
biosensing operations to be performed at the microscale, most infectious disease 
applications still require extraction and concentration of target nucleic acids from 
samples to reach a suitably low limit of detection (LOD). Concentration process is 
typically accomplished by either physical processes (e.g., centrifugation) or chemical 
amplification (e.g., PCR). Centrifugation is generally difficult to miniaturize and 
interface with microfluidic components, while techniques like PCR are not 
straightforward to apply when the sample of interest contains multiple components or is 
unknown. Moreover, the reaction products contain enzymes, primer oligonucleotides, 
and other chemical species, which are unique and expensive, in addition to the target 
nucleic acid often making it is necessary to incorporate additional purification steps prior 
to subsequent analysis. Thus, recent efforts have focus on technologies that allow a 
lower LOD[53], reduce the number of PCR cycles or even relax the need of a PCR step 
completely[54].   
 
1.3.4 Detection System Needs to Be Merged and Minimized 
Nucleic acid amplification can be analyzed after the reaction (endpoint detection) 
or while the reaction is progressing (real-time detection), but both of them relay on 
fluorescence detection, which requires optical excitation, involving gas lasers or high 
power broadband source and it is very difficult to merge into a microfluidic platform as 
mentioned earlier before. Most current POC NAT platforms are based on real-time 
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fluorescence detection (Table 1.3), which requires relatively expensive and complex 
instrumentation, but superior for quantitative analyte detection. Recent studies have 
focused on label-free technologies by replacing the readout of fluorescence intensity 
with electrical readout. However, most label-free detection technologies involve the 
nucleic acid immobilization based on surface charge change[55] or diameter change[56] 
after DNA hybridization or direct detection of DNA hybridization on Metal-Oxide-
Semiconductor Field Effect Transistor (MOSFET) gate[57]. Those methods need 
relatively high-cost manufacturing and packing and suffer from the changes must not be 
screened by the solution. For example, the limits of the salt concentration in solution to 
values of 0.005x phosphate buffer saline (PBS) which is significantly below the 
physiological concentration[5] that it is impossible to meet the clinic demands. Thus, 
developing quantitatively detect label-free nucleic acid in free solution would introduce 
new opportunities to greatly simplify the physical and operational design of integrated µ-
TAS platforms. These capabilities also have the potential to enable the progress of on-
chip processes to be observed and regulated in real-time. 
 
1.4 Motivation and Objectives 
POC NAT is still in the emerging stage, in particular of the microfluidic-based 
methods. Figure 1.2 has been demonstrated the ideal microfluidic POC device, in fact, 
the imagined ideal POC device does not exist at this moment but crystallizing a vision to 
help us identifying the desirable characteristics of the requirements on progress in the 
field of microfluidic POC. Although no method is clearly superior and most technologies 
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are still at the laboratory-based research stage, there is a strong demand of a cheap, rapid 
and simple to use POC diagnostics device for the coming future. Generally, microfluidic 
devices are often first developed in research laboratories by integrating complex 
concepts into a single device, and then following the original prototype to simplify the 
technology while preserving its performance. Many promising technologies are still at 
the early research stage and will need fundamental innovations before clinical use, 
nevertheless, there will be always potential to move beyond benchtop-based approaches 
towards small POC handheld devices. Before that day coming, we still have a lot of 
work to do.  
 
In this study, we will focus on seeking new detection strategies (label-free 
detection) and new applications (encapsulated microbubble synthesis, protein 
crystallization) based on a versatile microfabricated electrode arrays and try to get the 
diagnostics method out of the laboratory (using pervasive smartphone optics). The 
specific objectives are as follows: 
 
• Develop a microfluidic platform for label-free detecting charged molecules 
in free solution by using a simple device design and minimal electrical 
power. We used unlabeled DNA as the beginning target to make it possible for 
detecting under very small potentials (1-3 V). The fundamental studies of the 
phenomena include several parameters, applied potential, initial DNA 
concentration, DNA length and amount of reducing agent, to verify the 
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mechanism and determine optimum operation condition. Furthermore, we 
applied this method to detect protein and small -molecule cyclodextrans as well 
(Chapter II). 
 
• Build a novel unlabeled detection method based on the electrochemical 
reaction by using the microfabricated chromium electrode arrays with 
smartphone optics. We used chromium as the studying material to fabricated 
microelectrode arrays. Since chromium is highly reactive and may 
unintentionally participate in the electrochemical reaction[58], we propose to 
harness this reactivity as the basis of a new detection method whereby the rate 
of electrode degradation is monitored and correlated with compositions of the 
bulk solution. The fundamental parameters to be studied including reducing 
agent amount, initial DNA concentration, DNA length, and buffer solution type 
to establish the sensitivity and detection limits. Furthermore, we applied this 
novel approach combine with smartphone optics to create an opportunity for a 
lighter weight telemedicine interfaces for a near-POC NAT application. 
(Chapter III). 
 
• Apply the DNA label-free detection methodology and hardware to 
establish a new application for synthesizing encapsulated microbubbles. 
We apply the above DNA label-free detection method in the presence of 
surfactants instead of DNA to make it possible to produce discrete stabilized 
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microbubbles. The surfactants include anionic surfactant sodium dodecyl 
sulfate (SDS) and cationic surfactant dioctyl sodium sulfosuccinate (AOT) 
under different critical micelle concentration (CMC) to establish optimal 
conditions and the governing parameters include electric field (amplitude, 
frequency, etc), buffer (type, concentration), and viscosity of bulk solution to 
enable production of microbubble of controlled size (Chapter IV). 
 
• Exploit an innovative application for protein crystallization by using the 
on-chip microfabricated electrode arrays. We used hen egg white lysozyme 
as a model protein to explore the capability of a fast and easy strategy for on-
chip protein crystallization via electrokinetic actuation. The aim of this study is 
to investigate a technique for shorter induction times of the nucleation and for 







A MICROFLUIDIC PLATFORM FOR PRE-CONCENTRATION AND LABEL-
FREE DETECTION OF DNA BY USING ON-CHIP ELECTRODE ARRAYS∗ 
 
This chapter details a new technique we developed that can enable biomolecules 
(DNA, proteins) and other charged analytes to be detected in free solution without the 
need for conventional labeling with conjugated chemical fluorophores via a simple 
device design that consumes minimal electrical power.  We used DNA as a probe to 
study the morphology of the compacted macromolecular film and the kinetic mechanism 
to determine optimum conditions. Using this arrangement, we have shown that it is 
possible to detect a variety of analytes in free solution by simply illuminating the 
electrode surface with white light and observing the accompanying strong increase in 
reflected intensity. 
 
2.1 A New Label-Free Detection Approach Performed in Free Solution 
We proposed exploratory research to develop an electrokinetically actuated 
microbubble synthesis method that addresses the need of label-free detection by 
establishing localized zones inside a microchannel network where a charged 
biomolecule can become enriched to a very high concentration while simultaneously 
                                                 
∗ Part of the data reported in this chapter is reprinted with permission from: Tunable 
Synthesis of Encapsulated Microbubbles by Coupled Electrophoretic Stabilization and 
Electrochemical Inflation by Huang, Y.-W., Shaikh, F.A., Ugaz, V. M., Angewandte 




experiencing infusion with electrochemically generated gasses. The cornerstone of our 
approach is a microfluidic system incorporating arrays of individually addressable 
electrodes (patterned along the microchannel floor) that make it possible to transport 
charged macromolecules from the bulk solution to an electrode surface where they 
become compacted into an ultra-thin film (Figure 2.1 a)[59]. The compaction process is 
illustrated by observing the behavior of fluorescently labeled DNA in response to a 1 V 
DC potential applied across neighboring electrodes. The negatively charged DNA 
contained between active electrodes migrates toward the anode and experiences local 
enrichment, yielding a fluorescent zone at the electrode surface (Figure 2.1 b). 
Remarkably, we discovered that this compacted film can also be clearly seen under 
ordinary white light even when the DNA sample is unlabeled, with no excitation or 
emission filters in the optical path, which provide an opportunity for label-free detection 
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2.2 Morphological Characteristics of the Compacted DNA Layer  
To determine the morphology of the compacted macromolecular films, we 
repeated the above mentioned DNA capture experiments under transmitted illumination 
using optically transparent thin gold electrode arrays. We observed the process under 
polarized light which reveals dense stabilized microbubble clouds are embedded within 
the enriched DNA zones (Figure 2.3 a). These clouds emerge because the compacted 
macromolecular film imposes a barrier against transport of electrochemically generated 
gasses produced by hydrolysis, introducing a highly reflective topology that makes 
label-free detection possible. The microbubble clouds are spatially distributed such that 
their density is greatest near the microchannel sidewalls (Figure 2.3 b) or corners of 
electrodes that do not span the entire microchannel width (Figure 2.3 c, d) suggesting 
higher levels of DNA enrichment at these locations, likely owing to the steeper electric 
field gradients present there. Upon switching the potential to an adjacent electrode pair, 
the reflective zone remains largely intact as it migrates toward the new anode indicating 
that the microbubbles remain stably embedded within the enriched DNA zone (Figure 
2.3 e). Birefringent textures are also sometimes evident when viewed through crossed 
polarizers (Figure 2.3 f), suggesting local attainment of concentrations high enough to 
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We also observed the biomolecule compaction layer at the electrode surface 
using confocal laser scanning microscopy of fluorescently labeled DNA as a probe to 
obtain cross-sectional slice views with confocal laser scanning microscopy (Figure 2.4). 
By scanning the laser across successively higher planes above the electrode surface (~ 
2.5 µm resolution in the z-direction), we obtained a 3-D mapping of fluorescence that 
helped establish the spatial extent of the compacted layer near the electrode surface. This 
observation shows the DNA compaction layer is preferentially distributed near the 
microchannel sidewalls, most likely owing to the steeper electric field gradients present 
there. This information should, in principle, allow the concentration within the 
compacted layer to be quantified. But in practice, we found that reflection from the 
electrodes made it difficult to decouple the fluorescence signal due only to the captured 
DNA. Nevertheless, these experiments provide a useful qualitative picture of how DNA 






Figure 2.4 Confocal laser scanning microscopy provides a 3-D view of the 
electrophoretically compacted DNA layer. (a) Cross-sectional slice views of the DNA 
layer (100 bp dsDNA ladder labeled with YOYO-1 initially at 10 µg/mL in 50 mM 
histidine buffer, 1 V) before and after compaction. (b) Corresponding cross-sectional 
intensity profile above the electrode surface. Images were acquired using a confocal 
microscope (Leica) with a 10x objective (2x zoom) at 400 Hz scanning speed and ~ 2.5 
µm resolution in the z-direction. 
 
2.3 Macromolecular Transport and Compaction  
In previous group member’s studies, we have shown that compaction of charged 
biomolecules at the electrode surface is electrophoretically dominated[59]. Briefly, we 
consider the case of DNA and note that the process is performed in a sealed environment 
to prevent evaporation and confine the liquid within a fixed volume to restrict bulk flow 
(Figure 2.5). The underlying mechanisms can therefore be understood by considering the 
relative influence of electrophoretic, electroosmotic, and electrochemical effects 
(electrolysis of water becomes significant at potentials above ~ 1.3 V). Diffusion of 
compacted DNA molecules from the anode surface can be neglected by considering a ~ 
20 s compaction time, which yields a characteristic diffusion length scale of (2Dt)0.5 ≈ 8 
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compaction time, and D is the diffusion coefficient of DNA molecules (estimated to be 
1.4 x 10–9 cm2/s[64]). Additionally, dielectrophoretic effects are expected to exert a 
relatively small influence under these conditions because the DC electric fields are of 
comparatively low magnitude and not strongly divergent, except perhaps in the 
immediate vicinity of the electrode corners. 
 
 
Figure 2.5 Overview of key physiochemical mechanisms associated with 
macromolecular compaction and subsequent microbubble formation. Charged 
macromolecules are electrophoretically transported to the electrode surface where they 
are locally subjected to gas evolution due to water electrolysis. Oxygen is produced at 
the anode and hydrogen is produced at the cathode above a threshold potential of ~ 1.3 
V. 
 
To characterize the influence of electroosmosis, we note that electroosmotic 
pumping is localized between the active electrode pair inside the microchannel, in 
contrast to the more conventional configuration where an electric field is applied across 
the entire channel length. In this case of localized electroosmosis, the balance between 
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hydrodynamic effects inside and outside the actively pumped region results in a scaling 
of pumping velocity with applied potential between electrodes rather than electric field 
strength[65]. An estimate of the characteristic electroosmotic velocity can then be 
obtained from µEOF = εε0ζV/ηL, where ε is the dielectric constant of the buffer solution, 
ε0 is the permittivity of free space, ζ is the zeta-potential of the buffer solution, V is the 
applied potential, η is the fluid viscosity, and L is the entire length of the microchannel 
from inlet to outlet. Assuming characteristic material properties for water at room 
temperature (ζ = 100 mV for the silicon/glass surface[66], a 1 V potential and L = 3.1 cm) 
yields a value of µEOF ≈ 2.3 µm/s. 
 
An estimate of the characteristic electrophoretic migration velocity (µEP) can be 
obtained from the free solution mobility of double-stranded DNA (µ0 ≈ 4.5×10-4 cm2/V·s 
in TBE buffer[67]) and the electric field strength (E ≈ 40 V/cm), yielding a velocity of µEP 
= µ0·E ≈ 180 µm/s. This result can be used to estimate the time for DNA to travel across 
the entire 250 µm interelectrode spacing (~ 2 s). It can be seen that, µEOF is nearly two 
orders of magnitude smaller than µEP, which is calculated on an open channel 
configuration and expected to represent an idealized upper limit to the actual µEOF 
achievable in the sealed arrangement. Therefore, we can infer that the process by which 
the DNA migrates toward the anode and forms a compacted film occurs quickly, after 
which the confined DNA interacts with gasses evolved due to the electrolysis of water 




According to the abovementioned, collection and enrichment of charged 
macromolecules within these electrode arrays is electrophoretically dominated owing to 
their internal arrangement within an enclosed microchannel, rendering electroosmotic 
velocity proportional to the applied potential rather than the electric field[59] 
(characteristic electrophoretic velocities are ~ 100 times greater than those due to 
electroosmosis) — a feature that distinguishes this phenomenon from anomalous DNA 
condensation effects previously reported under AC fields[68, 69]. Consequently, the 
governing mechanism can be viewed in terms of a local competition between (i) 
electrophoretic transport and compaction of charged macromolecules from the bulk 
solution into a thin film at the electrode surface, and (ii) the gas-producing 
electrochemical reactions responsible for bubble formation (i.e., hydrolysis of water 
yielding oxygen at the anode and hydrogen at the cathode). Using DNA as a probe to 
explore these interactions, we observe that the compacted film is only visible with the 
aid of fluorescent labeling at potentials below the threshold for electrolysis (~ 1.3 V) 
(Figure 2.6 a). Microbubble clouds appear as the potential begins to exceed this 
threshold, accompanied by emergence of strong surface reflectivity (Figure 2.6 b). As the 
potential is increased further, locally oversaturated gasses begin to coalesce into larger 
bubbles at the cathode after several minutes, but not at the anode where the compacted 
DNA film is localized (Figure 2.6 c). This behavior is much different than would be 
expected if the stabilizing film were not present because oxygen bubbles produced at the 
anode generally exhibit weak adhesion to metal electrodes and should therefore coalesce 
to a larger size than the cathodically generated hydrogen[70, 71]. If the potential is applied 
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for a sufficiently long time, the stabilizing capacity of the macromolecular film saturates 
yielding coalescence at the anode, albeit to a lesser extent than at the cathode (Figure 2.6 
d). This coalescence ruptures the compacted film, an effect that becomes visible as a 
dark zone centered on the anode flanked by bright regions on either side when the DNA 
is fluorescently labeled (Figure 2.6 e). No surface reflectivity is evident when 
carboxylated polystyrene beads are substituted for DNA, indicating that the rigid 
microspheres are unable to adopt a sufficiently dense packing to stabilize a microbubble 
layer despite their enrichment at the anode. This mechanism can be further tuned by 
altering the interplay between electrochemical and electrophoretic effects as 
demonstrated by addition of sodium dithionite (Na2S2O4), a reducing agent that inhibits 
microbubble formation by establishing a competitive complexation interaction 
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reaching a plateau within ~ 60 s (Figure 2.8 a); and kinetics remain unchanged as the 
initial DNA concentration is varied from 10 to 50 µg/mL (Figure 2.8 b). Changes in 
DNA length influence the reflected intensity but do not strongly affect the kinetics, with 
T4 DNA (165 kb) able to stabilize larger microbubbles and generate stronger reflectivity 
than the much shorter 10 bp fragments (Figure 2.8 c). The corresponding time constants 
indicate that the kinetics maintain a similar order of magnitude across the entire 
ensemble of experimental conditions we investigated, implying that microbubble cloud 
formation is governed by a fundamentally consistent electrochemical mechanism (Table 
2.1). Addition of Na2S2O4 disrupts this balance, inhibiting development of the 
microbubble clouds and delaying attainment of an intensity plateau (Figure 2.8 d). But 
the magnitude and kinetics of surface reflectivity are eventually restored as the reducing 
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developed (MF-319 developer; Rohm & Haas Electronic Materials). Most studies were 
performed using platinum electrodes fabricated by depositing a 500 Å layer of titanium 
followed by a 1,000 Å layer of platinum using an electron beam evaporator. Transparent 
gold electrodes for experiments performed under transmitted light illumination were 
fabricated by depositing a 50 Å layer of chromium followed by a 200 Å layer of gold 
using a thermal evaporator. Glass microchannels were fabricated by depositing a 600 Å 
chromium layer followed by a 4,000 Å gold layer on glass wafers (borofloat, 500 µm 
thick, 15 cm diameter; Precision Glass and Optics) that had been cleaned in a reactive 
ion etcher. The wafers were then spin-coated with positive photoresist (Shipley 1827), 
patterned, developed with MF-319, and hard baked. After immersion for 10 min each in 
gold etchant (Transene) and chromium etchant (Cyantek), the exposed glass was then 
etched with a freshly prepared 7:3 (vol/vol) solution of hydrofluoric and nitric acids 
(etch rate ≈ 5 µm/min) to a channel depth of 45 µm (width = 275 µm). After dicing, 
fluidic access holes were drilled using an electrochemical discharge process. Silicon 
devices were mounted on printed circuit boards and wire-bonded to provide electrical 
connections. Glass microchannels were then bonded to the silicon device using a UV 
curable optical adhesive (SK-9 Lens Bond; Summers Laboratories). 
 
2.5.2 Sample Preparation 
Electrode capture experiments involving DNA were carried out using a 100 bp 
double-stranded DNA ladder (Bio-Rad) and monodisperse DNA samples with lengths of 
10, 100, 1000, 10 kb (Fermentas), 48.5 kb (λ DNA; cat. no. N3011S, New England 
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BioLabs), and 165.6-kbp (T4 DNA; cat. no. 318-03971, Wako USA). The DNA samples 
were suspended in TBE (extended-range TBE; Bio-Rad) and histidine (Sigma-Aldrich) 
buffers. Experiments investigating addition of a reducing agent were performed using 
sodium dithionite (Na2S2O4; Riedel-deHaën). Unlabeled samples were used as prepared, 
fluorescently labeled samples were prepared by adding YOYO-1 intercalating dye 
(Invitrogen/Molecular Probes) and β-mercaptoethanol (BME; Sigma–Aldrich) to inhibit 
photobleaching. Master mixes of fluorescently labeled DNA samples (10 µL) were 
prepared by adding the as-supplied DNA solution to 0.05 mM YOYO-1 intercalating 
dye in a 2:1 (vol/vol) ratio. After incubation for several minutes at room temperature, the 
suspension buffer was extracted with a vacuum centrifuge evaporator. The sample was 
then resuspended in the appropriate buffer system, and the desired amount of BME or 
reducing agent was added. Unlabeled DNA samples were prepared in the same way, but 
without addition of YOYO-1 and BME. 
 
2.5.3 Microdevice Operation 
DNA samples were loaded into the microchannel using a micro-needle tipped 
syringe, and access holes were sealed with removable adhesive to prevent evaporation. 
The same device could be used repeatedly for multiple samples after thoroughly rinsing 
with deionized water. Extensive comparison of results between new and reused devices 
indicated that no appreciable electrode fouling (as evidenced through accumulation of 
residue on the electrodes or glass channel walls and/or through significant deviations in 
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electrode capture response) occurred as a consequence of repeated use when this 
cleaning procedure was followed. 
 
2.5.4 Imaging and Detection 
The electrode capture process was imaged using an Axioskop-2 Plus microscope 
(Zeiss) interfaced with an Orca-ER digital CCD camera (Hamamatsu). A combination of 
Openlab automation software (Improvision) and ImageJ open source analysis software 
was used to acquire images and extract intensity data within a user-defined region of 
interest. Intensity versus time data were fit to a single-parameter exponential equation 
using Origin software (OriginLab Corporation). For flow visualization studies, a dilution 
of 1 µm-diameter, carboxylate-modified polystyrene microspheres (FluoSpheres; cat. no. 







UNLABELED DETECTION OF DNA VIA ELECTROCHEMICAL 
DISSOLUTION OF MICROFABRICATED CHROMIUM ELECTRODE 
ARRAY∗ 
 
This chapter provides a novel approach that enables unlabeled biomolecules and 
chemical analytes to be detected using ordinary smartphone optics, which expands the 
use of advanced diagnostic capabilities. Electrochemical reactivity of chromium, 
ordinarily considered detrimental, is harnessed here to generate a signature that can be 
easily seen by monitoring electrode degradation under ordinary white-light illumination. 
The simplicity and robustness of this approach eliminates the need for labeling and/or 
pre-programming with specific receptors (e.g., oligonucleotide probes), making it 
feasible to greatly expand availability of a host of assays where detection complexity is a 
limiting constraint. 
 
3.1 A Novel Unlabeled Detection Approach by Using Highly Reactive Chromium 
Electrode Array 
The ability to detect unlabeled analytes, particularly biomolecules representing 
specific targets of interest, is a key to enabling broad availability of inexpensive 
                                                 
∗ Part of the data reported in this chapter is reprinted with permission from: Smartphone-
Based Detection of Unlabeled DNA via Electrochemical Dissolution by Huang, Y.-W. 
and Ugaz, V. M., Analyst, 2013, 138, 2522-2526. Copyright [2013] by The Royal 
Society of Chemistry. 
 43 
 
diagnostic assays. Existing strategies predominantly involve introducing detectable 
probes that interact with the sample via chemical reactions or specific binding 
interactions with targeted receptors. Gold nanoparticles[75-79], quantum dots[80], magnetic 
nanoparticles[6, 81-83], and microfabricated cantilevers[84-86] have all been harnessed to 
enable sensitive optical and electrochemical detection of hybridization events. But these 
methods must be pre-programmed with appropriate receptor probes (e.g., 
oligonucleotides in the case of DNA detection) and often require multiple sample 
preparation and washing steps in order to perform optimally. If detection could be 
performed without labeling the sample or pre-programming the assay with specific 
probes, workflows associated with routine diagnostic assays (e.g., PCR) could be greatly 
simplified. This capability would be particularly beneficial in resource lean settings 
where a premium is placed on simplicity and robustness, as opposed to raw sensitivity[45-
49]. 
 
Here we report a new approach that addresses these needs by exploiting 
electrochemical reactivity of chromium to permit true label-free detection via an easily 
visible signature (Figure 3.1). Chromium's inherent instability, ordinarily considered 
undesirable, is advantageous here because the rate of electrode degradation strongly 
depends on the bulk solution composition. These kinetics therefore reflect an interplay 
between electrochemical dissolution and electrophoretic transport of analytes to and 
from the electrode surface. The process is easy to monitor because the electrodes are 
large enough to view using simple optics (e.g., a smartphone camera). 
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Figure 3.1 The microdevice design incorporates a glass microchannel (275 x 45 µm 
cross-section) bonded to a Si substrate patterned with a Cr microelectrode array. When a 
2.5 V potential is applied, the Cr electrodes electrochemically dissolve at a rate 
dependent on the chemical composition of the bulk solution (arrows). The dissolution 
process can be readily detected by observing the change in reflected light intensity from 
the electrode surface. 
 
To demonstrate the detection method, we constructed a microfluidic system 
incorporating an addressable chromium electrode array patterned along the microchannel 
floor (Figure 3.1) — an arrangement that allows very small potentials (2.5 V) to generate 
locally high electric fields (hundreds of V cm-1)[59, 87]. Electrode dissolution is monitored 
by recording the change in surface reflectivity with time under oblique illumination with 
ordinary white light, from which the average intensity within a region of interest 
centered on the electrode can be quantified. In this way, changes in dissolution rate in 
response to the bulk solution's chemical composition can be readily distinguished[88]. 
 
Despite its outward simplicity, the underlying chemical and physical processes 
governing electrode dissolution are relatively complex, owing to an interplay between 
electrophoretic transport of analytes toward and subsequent compaction at the surfaces 
of electrodes where the corresponding electrochemical reactions are localized. These 
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surface phenomena are in turn influenced by local pH, ionic environment, and the 
activity of side reactions. The pH of aqueous solution directly affects the solubility of 
metal compounds[89]; and higher ionic strength reduces the thickness of electrical double 
layer to replace the Cr ions with cations in the bulk solution to cause more rapid metal 
dissolution[89, 90]. Dissolution kinetics at the electrode surface in an aqueous acidic 
environment can be broadly characterized in terms of the following mechanism[91-93]. 
Cr + H2O ↔ CrOHads + H 
CrOHads + H3O+ → CrOH+ + H + H2O 
CrOH+ + H3O+ ↔ Cr2+ + H2O 
 
These kinetics are superimposed on corresponding reactions associated with 
electrolytic production of hydrogen and oxygen at the anode and cathode. The sensitivity 
of both these pathways to analyte composition forms the basis of our detection strategy. 
 
3.2 Compositional and Size Dependence of the Chromium Dissolution Kinetics 
We initially studied the fundamental performance of chromium electrodes by 
using fluorescently labeled DNA as a probe under different bulk conditions and recorded 
the change of fluorescent intensity as a function of time to obtain the reaction kinetics. 
The preliminary results show that the chromium electrode dissolution is highly related to 
the initial DNA concentration (Figure 3.2) and the compositions of buffer solution. This 
observation is promising to harness this reactivity as the basis of a new detection method 
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performed using a benchtop-scale microscope to observe the electrode dissolution 
process and record its time history for each sample composition. Our observations, 
shown in Figure 3.3 a, indicate several key trends. Electrode dissolution proceeds 
slowest in the near-neutral pH buffer environment, our base case for comparison. 
Addition of dsDNA accelerates the dissolution timescale somewhat, suggesting an 
influence of the electrophoretically compacted DNA film. Addition of a reducing agent 
at near neutral pH further accelerates dissolution, suggesting that its oxygen scavenging 
activity plays an important role. Finally, we observe that dissolution proceeds most 
rapidly in the low pH buffer. Good reproducibility was observed in all cases, with the 
only caveat being that a small degree of uncertainty was introduced because we 
manually synchronized actuation of the electrodes with the video recording. 
 
These observations highlight the importance of the local pH environment in the 
vicinity of the electrode in governing the electrode dissolution process. Compared to the 
base case of buffer at near neutral pH, dissolution kinetics are accelerated either by 
addition of a reducing agent or by pH adjustment to a lower value, reflecting the inherent 
pH dependence of the above mentioned kinetic mechanism governing dissolution. In 
addition to direct compositional adjustment, addition of a reducing agent may also act to 
lower the local pH by introducing an oxygen scavenging side reaction. The behavior 
observed upon addition of DNA is somewhat less intuitive. We hypothesize that the 
electrophoretically compacted DNA film may influence the process by imposing a 
physical transport barrier that acts to enhance the local hydrogen ion concentration 
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associated with the surface reaction products, yielding a local shift to lower pH that 
favors dissolution. The consequences of this interplay become further evident by 
comparing dissolution kinetics observed with DNA samples of different length (Figure 
3.3 b; all samples prepared at 20 µg mL-1 in 50 mM histidine). These data display 
dramatically slower kinetics with increasing DNA length, accompanied by a visible 
morphological change at the electrode surface where the uniform dissolution is seen in 
the 100 bp ladder sample assumes a speckled pattern characterized by discrete reflective 
spots at longer DNA sizes. These differences suggest potential for some degree of size-
dependent selectivity. 
 
Figure 3.3 Electrode surface reflectivity unfolds differently during dissolution involving 
different analytes. (a) Evolution of reflected light intensity from the active electrode 
displays composition-dependent behavior as evident by comparing dissolution kinetics 
of histidine buffer (50 mM, pH 7.6), a 100 bp dsDNA ladder (20 µg/mL in 50 mM 
histidine),  a reducing agent (0.06% w/v Na2S2O4 in 50 mM histidine), and at low pH (50 
mM histidine, pH 4.4). Results from two independent experiments are shown for each 
analyte to assess reproducibility. (b) The dissolution process evolves more slowly when 
DNA fragments of increasing length are probed (all samples prepared at 20 µg/mL in 50 
mM histidine). These differences are accompanied by a transition from uniform 





3.3  Possibility for Real-Time PCR Detection Application 
We next applied this approach to detect a 237 bp PCR product replicated from a 
λ-DNA template. The PCR products were loaded directly into the microchip with no 
additional labeling or purification steps. When viewed through a benchtop microscope, 
the electrode reflectivity data reveal a shift toward faster dissolution when the target 
DNA is present as compared to the pre-reaction control (Figure 3.4 a). Although various 
approaches can be envisioned to quantitatively report the change in dissolution kinetics, 
we chose as a first approximation to examine the shift in the time for the electrode 
reflectivity to attain a peak value before decreasing due to dissolution. This parameter 
offers the advantage of being relatively easy to establish independent of run-to-run 
variations in absolute reflected light intensity. Using this approach, we observed a shift 
of Δtmax = 11.3 s between the pre-reaction control and post-reaction PCR products 
(Figure 3.4 a). These results demonstrate feasibility to function for PCR product 
analysis. The above mentioned dependence of dissolution kinetics on DNA fragment 
length (see Figure 3.3 b) also introduce intriguing possibilities by observing how 
dissolution kinetics evolve during the course of PCR replication (Figure 3.4 b). The 
process unfolds reproducibly in both the pre-reaction control and after 30 cycles of 
replication. But the dissolution profiles display much more variability when examined 
after 15 cycles, generally reflecting a trend of slower kinetics that we hypothesize may 
be a manifestation of the presence of long DNA fragments of variable length produced 
during early cycles prior to the onset of exponential replication of the 237 bp target. The 
length distribution associated with these non-specific products is inherently variable 
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from run-to-run, potentially explaining the increased variability in dissolution rate 
observed at this stage of the reaction. It therefore appears feasible that dissolution 
kinetics could be exploited to extract information analogous to the critical cycle number 
(CT) marking the onset of exponential replication by simply observing the transition 
between reflectivity profiles characteristic of the pre- and post-reaction samples. This is 
an important parameter that is widely employed to quantify a sample's starting 
concentration of template DNA, but is predominantly measured using fluorescence-
based real-time PCR instrumentation. 
 
Figure 3.4 PCR products can be detected by observing electrode dissolution kinetics. (a) 
Accelerated dissolution kinetics are observed in the presence of the post-PCR products, 
as compared with the pre-reaction control. The time to reach a peak reflective intensity 
value before decreasing due to dissolution (Δtmax) offers a convenient observable 
parameter that is independent of run-to-run variations in absolute reflected light 
intensity. Results from two independent experiments are shown for each analyte to 
assess reproducibility. (b) Dissolution kinetics evolve differently at intermediate cycles 
of the PCR, likely owing to the presence of longer non-specific products produced at 
early stages of the reaction, potentially providing a way to determine the onset of 





3.4  Application for Smartphone-Based Detection of Unlabeled DNA 
Since dissolution is readily observable under white light illumination owing to 
the relatively large electrode sizes involved, our method offers potential to function 
using optics at the level found in current-generation smartphones. Preliminary studies to 
demonstrate feasibility of smartphone-based imaging were performed with an Apple 
iPhone 4S using the iFast Pro camera app (enabled an 8x digital zoom to be applied 
during recording). The video files were exported as grayscale TIFF stacks and processed 
by the same workflow used in the benchtop experiments. A snap-on mini microscope 
(<$10 US; http://www.amazon.com[94]) was used to achieve increased magnification 
(Figure 3.5).We used only the mini-microscope's built-in LEDs for illumination in the 
smartphone experiments. Although electrode degradation could be clearly recorded, the 
camera's limited resolution and weaker LED illumination (only the mini-microscope's 
built in light source was used) introduced some variability in the absolute intensity scales 
that was challenging to systematically address. Instead, we examined the local intensity 
maximum on the electrode occurring shortly after application of the potential and 
compared the difference between values recorded in the PCR (post-reaction) and control 
(pre-reaction) samples (see Figure 3.4 a). Clear shifts were evident, with the intensity 
maximum occurring Δtmax = 11.3 and 13.0 s as determined using the benchtop 
microscope and smartphone camera respectively. While a number of snap-on 
microscope accessories are available that can be interfaced with smartphones, we chose 
this type of microscope because it is inexpensive and widely used for currency detection. 
Although we selected an iPhone to demonstrate proof of concept, this approach can be 
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generically applied to a variety of smartphones, and is likely to become increasingly 
robust as imaging capabilities continue to rapidly improve. 
 
Figure 3.5 The microelectrode arrays are large enough to enable dissolution to be 
directly imaged using an ordinary smartphone (Apple iPhone 4S). Scale: all electrodes 
are 50 µm wide horizontally. 
 
3.5  Possible Approaches for Quantification and Explication of the Dissolution 
Kinetics 
Several approaches can be developed to quantify the dissolution kinetics and to 
examine the possible mechanisms governing the electrode dissolution (Figure 3.6 a). 
Since the heterogeneity in the numbers renders difficult statistical analysis, we 
performed data normalization to scale the original surface intensity and to favor the 
comparison from different batches of experiments. Here, we chose the method with 
respect to the initial and final values, Inormalized = (I – Ifinal)/(Iinitial – Ifinal), to set the initial 
and final stages equal to 1 and 0 respectively. Then, the underlying mechanisms can be 
understood by considering various parameters presented on the kinetics profile. In 
previous studies, we have shown that DNA molecules compact immediately (~ 20 s) and 
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Table 3.1 Normalized kinetics parameters associated with two electrochemical 
reactions, electrolysis of water and chromium dissolution, in unlabeled DNA detection 
experiments. All experiments were performed at a potential of 2.5 V and data is 





tmax tcross Imax S1 S2  S1 S2 
Buffer 
40 84.0 1.38 0.0093 0.0402  0.0900 0.5089 
45 82.0 1.43 0.0099 0.0486  0.0887 0.4749 
DNA 
25 78.4 1.14 0.0057 0.0242  0.0465 0.2018 
25 79.3 1.27 0.0061 0.0236  0.0421 0.2199 
RA 
5 44.59 1.051 0.0102 0.0330  0.4026 1.3067 
5 45.08 1.069 0.0138 0.0332  0.5090 1.2254 
pH 
5 19.69 1.003 0.0005 0.0668  0.0216 2.7258 
5 19.57 1.010 0.0020 0.0651  0.0582 1.9119 
 
 
Although Table 3.1 provides several viewpoints to examine the possible reaction 
processes, the over-simplification however cannot view the underlying mechanisms 
completely. The addition of hydrogen ions under low pH condition, for instance, speed 
the chromium dissolution but the oxygen produced reaction also provides hydrogen ions. 
In addition, the electrolysis of water proceeds continuously at the potential above ~ 1.3 
V which makes it becomes difficult to cut these two reactions at any point. Furthermore, 
the data normalization set the initial and final stages are the same at all conditions which 
is like to tie the heads and toes of the curves and twists them to acquire the values of 
slopes (Table 3.1 and Figure 3.6 b) that are somehow different with the slopes obtained 
from the original data and cause misinterpretation of the kinetics in some way. The 
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3.6 Progress and Outlook 
We emphasize that the envisioned application for this technology is as a 
detection method for PCR-based assays. In this context, it is expected that products from 
a single reaction will be repeatedly analyzed, and that robust reaction conditions 
maximizing replication of the desired product have already been identified. In other 
words, our approach would be analogous to SYBR Green-based PCR analysis in the 
sense that the observed optical signal may not strongly discriminate between the product 
and any primer-dimers that may be present in an unoptimized reaction. In this scenario, 
that of a repeated robust diagnostic test, our approach offers a considerable advantage in 
terms of simplicity that outweighs some loss in overall selectivity. Therefore, while we 
do not anticipate that this method will be able to match the ultra-sensitive detection 
levels of conventional label- and/or probe-based approaches, the ability to detect 
analytes like PCR products using relatively crude smartphone-based optics is desirable 
in many settings. This capability is particularly remarkable considering that no labeling 
additives or chemical probes (e.g., sequence specific oligonucleotides) of any kind are 
employed. The same attributes that make chromium a poor choice for conventional 
electrochemistry (i.e., high reactivity) are precisely those that enable this approach to 
rapidly produce a visible signature representative of the analyte. Specificity can be 
enhanced by embedding tailored chemical functionality within the electrodes, albeit at 
the expense of added complexity. A further benefit of the chromium-based format is the 
ability to directly employ standard photomask plates as devices when optically 
transparent substrates are desired. Photomask manufacture is a standard process that 
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inherently yields precise patterning and is widely available for small-batch fabrication 
needs so that new designs can be easily tested. This favorable combination of attributes 
make our approach a good candidate to greatly expand the use of advanced diagnostic 
capabilities, particularly in resource-lean settings where simplicity and robustness are 
paramount[2]. 
 
3.7 Materials and Methods 
The setup and measurements of above the experiments are as follows: 
 
3.6.1 Microchip Fabrication and Assembly 
Design, construction, and operation of the microfabricated electrode array 
devices has been described in detail previously[59, 87]. Briefly, silicon wafers (P(100), 500 
µm thick, 15 cm diameter, 5000 Å oxide layer; University Wafer), were cleaned in a 
reactive ion etcher, spin coated with hexamethyldisilazane (J.T. Baker) followed by a 
positive photoresist (Shipley 1827; Rohm & Haas), patterned, and developed (MF-319 
developer; Rohm & Haas). Electrodes were fabricated by depositing a 600 Å chromium 
layer by thermal evaporation. Glass microchannels (275 x 45 µm cross-section) were 
etched on glass wafers (borofloat, 500 mm thick, 15 cm diameter; Precision Glass and 
Optics). Assembled devices were wire bonded to a printed circuit board so that 





3.6.2 Sample Preparation 
Electrode dissolution experiments were carried out using histidine (Sigma-
Aldrich), a 100 bp double-stranded DNA ladder (Bio-Rad), and sodium dithionite 
(Na2S2O4; Riedel-deHaën). Additional experiments were performed using λ-DNA 
(New England Biolabs) and a monodisperse 10 kb fragment (Fermentas). Test solutions 
were prepared in 50 mM histidine buffer. PCR products were generated using a KOD 
DNA Polymerase kit (Novagen) using a λ-DNA template (New England Biolabs) and 
primers obtained from Integrated DNA Technologies (forward: 
CTGAGGCCGGGTTATTCTTG; reverse: CGACTGGCCAAGATTAGAGA). 
Reactions were run for 30 cycles (95 °C, 10 s; 60 °C, 30 s; 72 °C, 30 s), and products 
were verifiedvby agarose gel electrophoresis. 
 
3.6.3 Microdevice Operation and Data Analysis 
Benchtop imaging was performed using an Axioskop-2 Plus microscope (Zeiss) 
interfaced with an Orca-ER digital CCD camera (Hamamatsu) and a halogen light 
source. A combination of Openlab automation software (Improvision) and ImageJ open 
source analysis software was used to acquire images and extract intensity data within a 
user-defined region of interest. Intensity profiles were normalized with respect to the 
initial and final values to facilitate comparison (Inormalized = (I – Ifinal)/(Iinitial – Ifinal); where 
I represents reflected intensity on an 8 bit scale of 0 to 255). The system’s current was 




TUNABLE SYNTHESIS OF ENCAPSULATED MICROBUBBLES BY 
COUPLED ELECTROPHORETIC STABILIZATION AND 
ELECTROCHEMICAL INFLATION∗ 
 
This chapter details the limitations of microbubble generation and storage can be 
overcome by exploiting an interplay between microscale electrokinetics and 
electrochemistry that simultaneously confines macromolecular encapsulants near an 
electrode surface while inflating them with gasses evolved from electrochemical 
reactions localized there. Stabilized microbubbles incorporating a remarkably broad 
range of morphologies produced by manipulating these fundamental processes. This 
versatility by generating dense clouds of small microbubbles that enable label-free 
detection of virtually any charged macromolecule (showed chapter II), and here by 
synthesizing larger discrete encapsulated microbubbles of tunable size will be displayed 
in this chapter. 
 
4.1 Challenges, Limitations and Applications of Microbubbles 
The inherent instability of microbubbles, gas-filled bubbles in the 1 – 50 µm size 
range, is a manifestation of the enormous Laplace pressures imposed by their highly 
                                                 
∗ Part of the data reported in this chapter is reprinted with permission from: Tunable 
Synthesis of Encapsulated Microbubbles by Coupled Electrophoretic Stabilization and 
Electrochemical Inflation by Huang, Y.-W., Shaikh, F.A., Ugaz, V. M., Angewandte 
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The resulting stabilized microbubbles offer unique properties that have long been 
appreciated in the context of affinity separations (i.e., colloidal gas apherons[107, 108]), and 
more recently as contrast agents for ultrasound imaging[109, 110], as well as convenient 
platforms for tethering chemical compounds (receptors, antibodies, etc.) to enable highly 
specific in vivo targeting (either to precisely deliver drug payloads or to locally destroy 
surrounding tissue when ruptured by an applied ultrasonic field)[102, 106, 111, 112]. But 
despite these exciting applications, conventional batch-scale approaches used to produce 
encapsulated microbubbles are often relatively crude, based on mechanical agitation to 
entrain surrounding gas. Incredible progress has been made toward development of 
improved strategies at both the macro-scale (e.g., sonication and emulsification[113-116]) 
and micro-scale (e.g., flow focusing and T-junctions[117-121]), but a critical need still 
exists for approaches offering greater robustness to tune microbubble sizes and 
properties, as well as providing scalability from large-batches to single-dose amounts. 
 
4.2 A Single Device for Tunable Size of Encapsulated Microbubble Preparation via 
Electrochemically Microfluidic Actuation 
Conventional processing techniques to produce encapsulated microbubbles, such 
as sonication and high shear emulsification, provide high yield and low cost, but poor 
control over the microbubble size and uniformity. This is a problematic because 
microbubble behavior depends very strongly on the size. For instance, increasing the 
microbubble radius from 1 to 10 µm will change the resonance frequency of an 
unencapsulated microbubble from 4.74 to 0.35 MHz[122]. Moreover, microbubble size 
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also affects the biodistribution and pharmacodynamics after intravenous injection, the 
bioeffects during ultrasound insonification and the gas release profile[123]. Microfluidic 
technologies, including flow focusing, T-junctions and coaxial electrohynamic 
atomization (CEHDA),  have been mainly focused on the microbubble preparation with 
a high degree of control over the size and polydispersity[124] (Figure 4.2). These 
techniques, however, have relatively low production rates and usually need multiple 
devices to produce the required microbubble yields due to the restrictions on surfactant 
concentration and liquid viscosity[123, 125]. Additionally, the necessary of operation in the 
clean room condition increases the cost of lithographic etching equipment, while the 
subsequent running costs are comparatively low. Table 4.1 compares the microbubble 
yields obtained from using different microfluidic technologies, which is an important 
consideration from a commercial point of view. Even though the yield of traditional 
sonication would be expected to be higher (~ 1 x 1010 bubbles min-1 or ~1 x 107 bubble 
ml-1[125]), the size distribution would be expected to be much broader (Figure 4.2) that 
the additional processing time is required to produce comparable monodispersible 
bubbles. Thus, it may be an acceptable trade-off in light of the development of 
























































































We proposed exploratory research to establish a new technique that will enable 
to synthesize a tunable size of encapsulated microbubbles by using a single microfluidic 
device. We have previously demonstrated a microfluidic device as abovementioned in 
chapter II, which can create a highly concentrated and compacted biomolecule film at 
the charged electrode surface and can be seen without chemical fluorophores labeled. 
This phenomenon has also been studied carefully in chapter II that charged biomolecules 
can become enriched to a very high concentration near an electrode surface while 
simultaneously experiencing infusion with electrochemically generated gasses to reflect 
injected light. A dramatic development is applying this same approach to synthesize 
encapsulated microbubbles by using ionic surfactants instead of DNA or protein (Figure 
2.1 and Figure 4.4 d). Since the gas bubbles produce from water electrolysis, the 
theoretical bubble growth rate will depend on the supplied electric potential under the 
constant temperature and pressure based on the Faraday’s law of electrolysis and the 
ideal gas law[72]. Therefore, we can regulate the supplied electric potential and the 
amplitude/duration to control the microbubble size and trigger the gas filled bubbles to 
depart from the electrode surface. In addition, the bubble growth process in polymers has 
been observed highly depended on the polymer concentration[126]. Thus, we can also 
adjust the concentration of surfactant concomitantly to produce tunable size of 






4.3 Surfactant-Coated Microbubbles Formation via Different Power Strategy 
We demonstrate this new approach by using ionic surfactants, such as sodium 
dodecyl sulfate (SDS) and dioctyl sodium sulfosuccinate (AOT), to make it possible to 
produce discrete stabilized microbubbles. Since SDS forms anionic micelles and AOT 
forms cationic micelles when the concentration above the critical micelle concentration 
(CMC) and electrolysis of water is responsible for the bubble formation, we expect to 
see oxygen filled SDS shell bubbles at the anode and hydrogen filled AOT shell bubbles 
at the cathode. Theoretically, oxygen and hydrogen start to be produced at the threshold 
potential of ~ 1.3 V. The practical potential, however, observed to generate 
microbubbles is higher above ~2.5 V both on SDS and AOT cases, which is referred to 
as overvoltage in electrochemistry commonly examined due to nonequillibrium kinetics 
of electron transfer, especially when a gas phase is present[127]. In addition, the speed and 
type of microbubble formation also depend on the supplied potential. At the bulk 
conditions slightly below the CMC, it takes longer time and higher potential to produce 
the locally oversaturated gases and form bubbles (Figure 4.3 a). When the condition 
reached the CMC, the aggregates of gas filled micelles is seen apparently at the charged 
electrodes within a minute (Figure 4.3 b). At a later time, the locally oversaturated gases 
begin to coalesce into larger bubbles after several minutes (Figure 4.3 c). At the 
condition greater than the CMC (~ 10x CMC), encapsulated microbubbles are 
continuously produced. To precisely control the size of microbubbles, we have to 
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continuously produced by water electrolysis, we applied a higher potential in a very 
short time (~ several seconds) to speed up the tiny bubble formation. Then, a lower 
potential was applied to keep on the electrochemical gases producing for a while to 
balance the gases inside and outside the micelles till the equilibrium accomplishment 
(Figure 4.3 e). An advanced approach is to operate at regular potential we used to for 
surfactant migration and compaction, and then to apply a higher potential in a very short 
time (~ several milliseconds) for increasing the speed of electrochemical gases 
production to release the encapsulated microbubbles into bulk solution (Figure 4.3 f). 
The former approach produces more uniform microbubbles, but the latter approach 
provides larger amount of microbubbles. 
 
4.4 Surfactant-Coated Microbubble Formation under Different Surfactant 
Concentration 
Gas bubble generation in polymers is more complicated than the corresponding 
problems in a pure substance[128]. Deng P. et al.[126] investigated microbubble formation 
in DNA solution, which shows the microbubble growth process, including bubble 
diameter, lifetime and nucleation work, is highly related to DNA concentration and 
viscosity. Here, we applied this new approach in the presence of an anionic surfactant 
sodium dodecyl sulfate (SDS) instead of DNA to produce discrete stabilized 
microbubbles. Our study also confirmed that the surfactant concentration dominate the 
microbubble formation. At bulk conditions below the critical micelle concentration 
(CMC; a value of 8.3 mM was assumed[129]), surfactant molecules become compacted at 
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the anode in the same way as the DNA behavior described in  chapter II but do not attain 
a sufficiently dense packing to produce strong surface reflectivity (Figure 4.4 a). Under 
conditions in the vicinity of the CMC, the electrode surface is initially decorated by a 
field of reflective spots sparsely arrayed against a dark background, transforming into a 
dense halo at later times and/or higher potentials (Figure 4.4 b). At still higher surfactant 
concentrations (~10x CMC), a more dramatic change occurs whereby discrete 
encapsulated microbubbles are continuously produced and released into the bulk 
environment (Figure 4.4 c). This behavior can be explained by noting that above the 
CMC micelles from the bulk solution experience compaction at the electrode surface, as 
opposed to the individual surfactant molecules that predominate at lower concentrations 
(Figure 4.4 d). The relatively large size of these micellar structures imposes a steric 
barrier against adoption of the densely packed arrangement necessary to generate high 
reflectivity. But because they are immobilized in close proximity to the electrode 
surface, the compacted micelles become infused with the electrochemically evolved gas, 
thereby providing a driving force for production of encapsulated microbubbles. The size 
and quantity of the resulting microbubbles can be manipulated by adjusting the 
amplitude and duration of the applied potential, which simultaneously governs the 
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Dioctyl sodium sulfosuccinate (AOT) is an anionic surfactant as well which is 
soluble both in polar and apolar solvents but forms reverse micelles with a unique 
cationic surface (Figure 4.5 a) and has been regarded recently for encapsulated 
proteins[130, 131]. When mixed with water, AOT dissolves if its concentration is less than 
the CMC (a value of 2.24 mM was assumed[132]). For concentrations above the CMC, 
however, aggregates in equilibrium with individual surfactant molecules are formed. We 
also examined AOT by using our new approach to produce stabilized microbubbles. At 
bulk conditions closed to the CMC, a longer time (~ 15 min) has to be taken to enable 
micelle cloud visible at the cathode comparing to the similar condition of SDS (Figure 
4.5 b). A denser surface reflectivity shows on the cathode under the slightly higher 
concentration above the CMC (~ 5x CMC) while larger coalescent bubbles form at 
higher potentials and longer times (Figure 4.5 c). Under the concentration far above the 
CMC (~ 20x CMC), aggregates is evident and a halo forms around the cathode due to 
the repellent from locally gases (Figure 4.5 d). Then, non symmetrical bubbles form at 
longer times (~ 10 min) with bigger diameters, which are not to be compared with the 
SDS bubbles (Figure 4.5 e) because the hydrophobic tails displayed on the surface of 
reverse micelles weaken the capability to stabilize gases. Previous studies demonstrated 
that bubble size and collapse process are retarded at high DNA/polymer concentrations 
due to increased viscosities[101, 104, 126, 133]. Therefore, we added glycerol and increased 
the CMC of SDS to raise the bulk viscosity and generated continuously discrete 
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4.5 Materials and Methods 
The design, construction, and operation of the microfabricated electrode array 
devices have been described in chapter II. Sodium dodecyl sulfate and dioctyl sodium 
sulfosuccinate (electrophoresis grade; Fisher) solutions were prepared in 50 mM 
histidine buffer. The encapsulated microbubbles produce process was imaged using an 
Axioskop-2 Plus microscope (Zeiss) interfaced with an Orca-ER digital CCD camera 
(Hamamatsu). The supplied potentials were provided by Agilent E364xA dual output 
DC power controlled by LabVIEW (National Instruments) to precisely regulate the 






APPLICATION OF ON-CHIP ELECTRODE ARRAYS FOR 
ELECTROKINETICALLY ACTUATED PROTEIN CRYSTALLIZATION 
 
This chapter displays an innovation we exploited for easy and rapid protein 
crystallization via electrokinetic actuation which simultaneously pre-concentrate protein 
molecules and migrate ions either to accelerate the process or to control the directions of 
the movement of certain ions. Protein crystallization is the bottleneck to obtain for the 3-
D structural analysis which normally requires days to weeks from a concentrated pure 
solution. Here, we used hen egg white lysozyme as first study to demonstrate an on-chip 
method that is possible to achieve single crystals using small power (< 2 V) within a 
short timescale (1-2 hours) and without previous purification that provides capabilities 
for a straightforward interface of in-situ x-ray diffraction analysis to be performed as the 
protein formed inside the system.  
 
5.1 Challenges and Conventional Methods of Protein Crystallization 
Protein crystallization was first carried out 170 years ago[134]. Early workers 
focus on purification to establish the nature of proteins and their role in catalysis until 
the x-ray diffraction developed to provide structural information at atomic-resolution in 
the 1950s[135]. Today, we understand that protein biomarkers play a critical role in 
biomedical screening, disease detection, identification of therapeutic targets, and 
monitoring treatment efficacy. But transformative advances in molecular-level 
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technologies for biomarker analysis and discovery are still necessary in order to 
overcome the barriers hindering development of more effective disease- and patient-
specific therapeutics. While computational methods have greatly improved the capability 
to predict structure-function relationships, the sheer number of interactions involved 
pose daunting challenges that make it essential to conduct parallel experiments so that  
the predictions can be validated and refined[136, 137]. In addition to fundamental biological 
insights, protein structure determination is indispensable in the pharmaceutical industry 
where it plays a key role in guiding the development of new drugs and therapeutic 
compounds[138]. Knowledge of the detailed structure associated with an active site 
governing protein activity provides a natural target for design of compounds to regulate 
metabolic pathways corresponding to the disease or infection of interest. This knowledge 
in turn makes it possible to develop new drug compounds that influence such behavior. 
Finally, high throughput structural characterization methods are urgently needed to 
perform population-scale studies aimed at obtaining data to serve as inputs for structural 
biology and structural genomics research efforts[139]. 
 
5.1.1 The Challenges 
Why are proteins generally more difficult to crystallize than small molecules and 
inorganic compounds? The main reason may be protein crystals have far few contacts in 
proportion to their molecular weight and are very weak even though the protein-protein 
contacts are comparable in binding energy to those between small molecules[135]. In 
addition, it is very difficult to purify proteins even with 100% chemical purity and each 
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individual molecules exist different conformational states which even militate against 
formation of highly ordered crystals. Furthermore, the diversity of chemical groups 
involve in the contacts of protein crystals that imply slight changes in pH, ionic strength, 
temperature, or concentration of an auxiliary ion or molecule may strongly influence 
crystallization processes.  
 
Currently, x-ray crystallography is the primary experimental tool employed to 
understand the fundamental processes that govern how proteins fold and assemble into 
well-defined structures because it delivers the molecular-scale resolution needed to 
elucidate relevant morphological details. But diffraction methods critically depend on 
the ability to produce high-purity crystal samples. Conventional crystallization processes 
are also inherently slow, involving suspending a protein of interest in an appropriate 
buffer solution and progressively increasing its concentration until supersaturated 
conditions are reached that favor nucleation and growth[140]. In order to drive the 
crystallization process, it is necessary to bring the protein laden solution into a 
supersaturated state. But the non-equilibrium nature of the supersaturation regime makes 
it challenging to precisely control, and the situation is further complicated by the wide 
range of parameters that can be varied. All the challenges point to the need for new 






5.1.2 Conventional Methods of Protein Crystallization 
The present state-of-the-art in protein crystallization can be understood by 
considering the range of supersaturated conditions that can be probed using various 
approaches (Figure 5.1)[140]. In microbatch methods (Figure 5.1, line i), the starting point 
is a supersaturated solution with an initial protein concentration just inside the nucleation 
zone where crystallization is favored. In practice, it is desirable to reduce the concentration 
into the metastable region (where a phase transition can occur but may not be 
thermodynamically favored) as soon as crystallization begins in order to maximize the size 
of the crystals produced. Robots can dispense thousands of microbatch trials down to 
nanoliter volumes that can be harnessed for screening, fine-tuning and optimization 
experiments[138]. Vapor diffusion methods (Figure 5.1, line ii) begin with an 
undersaturated protein solution that is brought to supersaturation by gradual evaporation. 
The most common variation is the hanging drop approach. A broader range of metastable 
conditions can be explored, but the rate of concentration change decreases with time. In 
addition, the different trials are not easily transportable that a comparably large minimum 
quantity of protein may be required[138]. Dialysis method (Figure 5.1, line iii) provides a 
way to further tailor exchange between the protein solution and a precipitant across a 
semi-permeable membrane but requires expertise. Free interface diffusion (Figure 5.1, line 
iv) allows more complex phase trajectories to be followed by establishing a concentration 
gradient between the protein and precipitant that makes it become the most powerful as a 
fine-tuning screening technique. In all procedures, timescales of days to weeks are 
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required to obtain diffraction quality crystals, and the methodology for zeroing-in on ideal 
crystallization conditions is still hit or miss. 
 
 
Figure 5.1 Simplified phase diagram for protein crystallization[140, 141]. Adjustable 
parameters include precipitant or additive concentration, pH and temperature. The 
overview of traditional crystallization methods is represented: (i) microbatch, (ii) vapor 
diffusion, (iii) dialysis and (iv) free interface diffusion. Each involves a different route to 
reach the nucleation and metastable zones, and all require long timescales (days to 
weeks). Copyright 1998 International Union of Crystallography. 
 
Microfluidic methods have proven to be a key enabling technology to address 
some of these barriers, most notably by increasing throughput via massive parallelization 
so that more trials can be performed simultaneously[142, 143]. Some adaptations also 
permit in-situ x-ray diffraction analysis, eliminating the need to harvest and manipulate 
the crystals. But in the majority of these formats, the fundamental mechanism by which 
the crystallization process is executed remains identical to the macroscale, with the 
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exception that the size of the container encapsulating the crystallization solution is 
greatly reduced[144-153]. Timescales of hours to days are generally required. 
 
5.2 New Strategy for Protein Crystallization Using an Internal Electric Field 
High-quality single crystals are extremely demanded for x-ray crystallography 
and they need a well-controlled nucleation process. To avoid uncontrolled nucleation, 
researchers often use seeding techniques to induce crystallization from metastable 
solutions, in which nucleation does not occur[154]. Other studies have considered a 
diversity of physicochemical parameters to control the nucleation phenomena, including 
using magnetic fields[155, 156], high-pressure[157, 158], ultrasonic fields[159], and electric 
fields[160-175]. The basic idea behind all of them is to locate the system in the nucleation 
area (Figure 5.1) and to provide energy for spontaneously producing the first nucleation. 
Among them, applying electric fields is the most direct and easiest approach. 
   
The electric-field-induced protein crystallization can be classified into external 
and internal electric fields, depending on whether the electrodes are directly in contact 
with the protein solution (Figure 5.2). Normally, external electric field trials require high 
fields of up to 7.5 kV cm-1 [160-162, 166] but no chemical reactions occurring on the 
electrodes. The first study of internal-electric-field-induced protein crystallization was 
introduced by Chin et al [176], called electrophoretic diffusion, to crystallize a labile 
enzyme (human placental estradiol 17β-dehydrogenase) that could not been crystallized 
by other methods with a relatively small electric field (initially 15 - 20 V cm-1 and then 
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30 - 40 V cm-1) and completed in 24 - 48 hours. Furthermore, Moreno’s group [168-170] 
demonstrated a new technique, electrochemically assisted protein crystallization, to 
crystallize lysozyme at cathode and to obtain amorphous phase at anode with ~1 V and 
~24 hours. Generally, applying electric fields influence the orientation of protein 
molecules that speeds up the nucleation velocity and reduces the induction time, but a 
supersaturated and metastable protein solution is still required for these procedures.  
 
 
Figure 5.2 Experimental set-ups of a crystallization cell using an external and an 
internal electrical field, respectively[168]. For the external-electrical-field-setting, the 
electrodes are not in contact with the solution containing the interested proteins. On the 
contrary, the electrodes are directly in contact with a protein solution, called internal-
electrical-field-setting. Copyright 2008 American Chemical Society. 
 
We propose exploratory research to establish a transformative and fundamentally 
different approach to direct the protein crystallization process from un-purified and un-
concentrated solutions by applying an internal electric field (Figure 5.3 a). Instead of 
increasing protein concentration throughout the entire bulk volume using evaporation, 
we propose to use microfabricated electrode arrays to increase protein concentration to 
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5.3 Preliminary Studies of Lysozyme Single Crystals 
In order to demonstrate our proposed concept, we performed preliminary studies 
to demonstrate its feasibility using hen egg white lysozyme as a model protein (Figure 
5.4). All experiments were performed using a commercial crystallization kit. A freshly 
prepared solution was injected into a glass microchannel with gold electrodes and the 
loading ports were sealed to prevent evaporation (Figure 5.3 a). A 2 V potential was then 
applied between electrodes in the array. Within 1 min, formation of a dense halo of 
compacted protein around the outer perimeter of the cathode was observed. Next the 
voltage switched off to release the compacted protein zone back into the bulk solution. 
In the absence of the electric field, large single protein crystals appeared within ~1 hour. 
Parallel negative control experiments in which the electric field was not applied did not 
produce crystals after several days.  
 
These results can be explained by considering the interplay between 
electrophoretic transport of the protein macromolecules and small-molecule ionic 
species present in the solution. When the potential is applied, the small-molecule species 
are likely to exhibit a higher mobility, resulting in rapid establishment of a dense cloud 
around the electrodes. In this stage, crystallization is suppressed due to this non-
equilibrium ionic environment and/or conformational changes in the protein near the 
electrode surface. When the potential is switched off, the compacted protein halo begins 
to disperse and re-enters more favorable ionic conditions. The protein concentration 
within this front remains high enough to lie within the supersaturated regime, enabling it 
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to act as a trigger for crystallization, thereby explaining the formation of crystals at some 
distance away from the cathode. The electric field is not applied during the 
crystallization process itself, it serves as an initial pre-concentration step for protein 
molecules and also provides directions of the movement of certain ions to accelerate the 
crystallization process. Although these are extremely preliminary results, we believe that 
the good repeatability we have observed with the process as depicted in Figure 5.4 
demonstrates that this crystallization approach is feasible as a reproducible trigger for 
rapid protein crystallization.  The results of the real-time x-ray diffraction for the crystal 
structure analysis did not apply to our work yet, but the ability to form diffraction quality 
crystals in the presence of an applied electric field has been previously demonstrated in 
the context of conventional macroscale methods [165, 170, 172, 175]. Thus, we believe this 
new technique has capability to enable protein to be rapidly crystallized and their 
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CONCLUSIONS AND FUTURE WORK 
 
6.1 Summaries and Conclusions 
In this study, we developed a versatile platform with addressable microfabricated 
electrode arrays (Figure 6.1). With slight modification of the electrode materials, this 
platform can provide multi-applications with small electrical power consumption (1–3 
V) via the microscale interplay between electrophoresis and electrochemistry.  
 
 
Figure 6.1 Illustration of microdevice construction and microfabricated electrode arrays. 
Diagram is reproduced from Shaikh and Ugaz (2006) [59]. 
 
Microfabricated platinum electrode arrays display the capability for a real label-
free detection to avoid the drawback of conventional labeling methods. This new 
technique allows biomolecules (DNA, proteins) and other charged analytes to be 
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detected in free solution via the surface reflectivity of stabilized microbubbls produced 
from the electrolysis of water, which has a threshold of ~1.3 V. This effect is reversible 
that enables for the subsequent reaction, and can be tuned to localize compaction by 
adjusting the buffer pH relative to the sample’s isoelectric point. The interplay between 
microscale electrokinetics and electrochemistry can also be harnessed to simultaneously 
confine macromolecular encapsulants near an electrode surface while inflating them 
with gasses evolved from the electrolysis of water localized there for imaging and 
targeted therapeutics. 
 
Microfabricated chromium electrode arrays demonstrate another application of 
unlabeled detection by monitoring electrode degradation under ordinary white-light 
illumination. The governing chemical and physical processes of the on-chip chromium 
electrode dissolution are relatively complicated but highly compositional- and size-
dependent, which provides a promising further opportunity for a real-time PCR detection 
application. In addition, preliminary studies also displayed the feasibility of smartphone-
based imaging with an Apple iPhone 4S using the iFast Pro camera app. The use of the 
existing hardware and/or software architecture of cell-phones to improve healthcare is a 
recently emerging topic since the world-population of at least one cell-phone 
subscription has been expected to further increase up to ~ 90% by 2015[178]. Our 
approach can be generically applied to a variety of smartphones, and is likely to become 
increasingly robust as imaging capabilities continue to rapidly improve, which will 
greatly expand the use of advanced diagnostic competences.  
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 Protein crystallization has been demonstrated by electrokinetic actuation 
simultaneously to pre-concentrate protein molecules and to migrate the movement of 
certain ions that enables to obtain single crystals in a short timescale (1-2 hours) and 
without previous purification. The use of transparent electrodes is essential to allow the 
observation of the crystallization processes under transmitted light through crossed 
polarizers and to provide the capabilities for a straightforward interface of in-situ x-ray 
diffraction analysis. 
 
6.2 Future Work 
Although we have successfully built a diversified platform for simply unlabeled 
detection, tunable synthesis of encapsulated microbubble and rapid protein 
crystallization, advanced investigation will allow us to precisely control this technique 
and to expand the abilities for multiple user communities. The following are 
recommended to further improve the performance and capability of our system. 
 
6.2.1 An Integrated Hydrodynamic Flow System 
The ability to transport and manipulate solutions in microchannels is one of the 
fundamental issues of microfluidics. Electroosmotic flows have been used to transport 
fluid at the microscale, but they are sensitive factors such as buffer properties, surface 
composition, and the electric field. Quake’s group[179] has developed a simple method to 
fabricate pneumatically activated valves on the basis of soft-lithographic procedure, 
which made a significant contribution. We have preliminarily followed the same 
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principles of the diaphragm valves[180] to create two layer pneumatic microvalves (Figure 
6.2 a, b) by using polydimethylsiloxane (PDMS), which can be operated as an efficient 
micropump by controlling the open/close of the microvalves via computer software 
(LabVIEW, National Instruments) adjusting the pressure in a displacement chamber on 
the pneumatic layer (Figure 6.2 c). We also have developed a clipped approach using 
transparent acrylic to incorporate the PDMS layer to our silicon/glass electrode array 
chips (Figure 6.3). This design solves the nonspecific absorption problem of PDMS and 
allows the silicon/glass chips to be reusable after cleaning. This micropump has been 
tested to inject dsDNA labeled with YOYO-1 for performing the buffer exchange 
(Figure 6.4). Even though this is a very beginning of the attempt, we believe further 
improvement of this microfludic system will have a better performance to collect 
targeted samples, to harvest desired crystals, and to continuously produce encapsulated 
microbubbles. In addition, an integrated on-chip microfluidic system as we endeavor to 
build up can also be used as a basic building block to construct highly sophisticated 
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6.2.2 Fundamental Characterization of Gas Evolution 
Electrolysis of water (with a threshold of ~1.3 V) is the main reaction of our 
system to dominate the performance of label-free detections and synthesis of 
encapsulated microbubbles. Therefore, the investigation of the fundamental 
characterization of oxygen/hydrogen evolution on the electrodes will allow us to 
precisely control this microfabricated system. Simultaneous real-time measurement of 
reaction current as a function of time can provide an idea of total electrical charges 
between the electrochemical reactions. Assuming electrolysis of water is the only 
applied coulometric gas generation reaction, which occurs if a current is sent through 
two noble metal electrodes placed in water in terms of the following mechanism. 
Anode: 2H2O → 4H+ + 4e- + O2 (g) 
Cathode:  2H2O + 2e- → 2OH- + H2 (g) 
 
Based on this reaction and assuming that all generated gases (O2 and H2) evolve 
in the form of gas bubbles, it can be derived that the total amount ௚ܸ௔௦ (m
3) depends 
linearly on the electrical charges Q (C). 
௚ܸ௔௦ ൌ  ுܸమ ൅ ைܸమ 








ܿ ൌ  ௠ܸ
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Where ுܸమ  and ைܸమ  are hydrogen and oxygen gas volumes, respectively; F is 
Faraday’s number (96.49 x 103 C/mol); ௠ܸ (m
3 mol-1) is the molar gas volume (24.7 x 
10-3 m3 mol-1, at 25 Ԩ  and atmospheric pressure); and ݅ሺݐሻ  (A) is the current as a 
function of time. Thus, we may be able to control the amount of gases produced from the 
reactions and to develop a micro-dosing system in the future.  In addition, using a high-
speed and high-resolution camera can help us to demonstrate the influence of 
microbubble size with the electric field[95, 181] (amplitude, frequency), bulk solution 
(type, ionic strength, and viscosity[133]), electrode material and roughness[96], and 
encapsulating materials[182] to establish the optimal conditions. 
 
6.2.3 Chemical and Physical Mechanisms of Chromium Electrode Dissolution 
The underlying chemical and physical processes governing the chromium 
electrode dissolution are relatively complex, but undoubtedly the changes of local pH 
and ionic environment by electronically active reactions play an important role. Deep 
investigation can help us to understand and develop the mechanisms and to optimize the 
performance of the micro-system. pH indicator provides a rough variation of the 
background electrolytes[183] but it may be difficult to observe clearly under a micro-
surroundings. Computational simulation may be a good tool to develop the local pH 
distribution and to understand the effect of buffer protonation under the local mass 
transportation and chemical reactions [184-186]. In addition, computational simulation can 
also build up the profile of DNA compaction on the polarized electrodes and know prior 
to any active microarray layout design to optimize the performance[187].   
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6.2.4 Advanced Studies of Protein Crystallization 
A mathematical model that describes accurately the crystallization process using 
an internal electric field is not yet available, and should be matter of interest for physical 
chemists[168]. This research will also give us more insights about the details of the 
crystallization process and will lead us to optimize the crystallization prior to using our 
system. In addition, developing a suitable microarray layout design to achieve enhanced 
compaction and nucleation of crystal growth, and if possible, to conduct several 
experiments at the same time with disposable materials would further increase the 
efficiency and reduce the cost of instrumentation. Patterning techniques [188-190] will 
allow us to induce a preferred surface alignment state at the electrode surface to promote 
nucleation and growth of single crystals for structural analysis. Coupling with x-ray 
diffraction to build up a real-time in-situ crystal structure analysis would be the goal of 
this study.  
 
6.2.5 A Microfluidic Electrochemical-Based Quantitative PCR (qPCR) Chip 
As abovementioned in chapter 3.3, we demonstrated a promising opportunity for 
real-time PCR detection and quantitation. In our knowledge, most common detection 
scheme for micro-PCR is based on fluorescence markers [191, 192]. Even though 
electrochemical-based detection has been reported currently, probe-modified electrodes 
and asymmetric PCR are still required to produce single-stranded target amplicons[27, 193, 
194]. Gong’s group[195] reported a relatively simple electrochemical-based micro-device to 
detect amplicons on bare electrodes via the changes of current signal of methylene blue 
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as an electrochemically active species in the PCR mixture. Comparing our approach with 
these above methods, recording electrode reflectivity via electrochemical dissolution on 
bare electrodes and without additives is much more straightforward and simple 
operation. Further study to establish the relationship with PCR cycle-by-cycle and the 
calibration curve based on the threshold cycle (Ct) and DNA concentration would 
provide in situ quantification of the PCR amplicon and decide the detection limitation. 
Advanced functionalization with heaters/temperature sensors and superimposing a 
hydrodynamic flow can be developed for an in situ qPCR micro-system in the future 
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